1 |
Zhuang J, Ping Q, Song Y, Qi J, Cui Z. Effects of chitosan coating on physical properties and pharmacokinetic behavior of mitoxantrone liposomes. Int J Nanomedicine. 2010. 5: 407 -416.
|
2 |
Prestegard JH, Fellmeth B. Fusion of dimyristoyllecithins vesicles as studied by proton magnetic resonance spectroscopy. Biochemistry. 1974. 13: 1122.
DOI
ScienceOn
|
3 |
Regen SL, Czech B, Singh A. Polymerized vesicles. J Am Chem Soc. 1980. 102: 6638.
DOI
|
4 |
Sihorkar V, Vyas SP. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. J Pharm Pharmaceut Sci. 2001. 4: 138-158.
|
5 |
Takeuchi H, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm. 2005. 303: 160-170.
DOI
ScienceOn
|
6 |
Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y. Mucoadhesion of polymer-coated liposomes to rat intestine in vitro. Chem Pharm Bull. 1994. 42: 1954-1956.
DOI
ScienceOn
|
7 |
Venkatesan N, Vyas SP. Polysaccharide coated liposomes for oral immunization-development and characterization. Int J Pharm. 2000. 203: 169-177.
DOI
|
8 |
Zhou F, Neutra MR. Antigen delivery to mucosa-associated lymphoid tissues using liposomes as a carrier. Biosci Rep. 2002. 22: 355-369.
DOI
ScienceOn
|
9 |
Zhu J, Yan F, Guo Z, Marchant RE. Surface modification of liposomes by saccharides: Vesicle size and stability of lactosyl liposomes studied by photon correlation spectroscopy. J Colloid Interf Sci. 2005. 289: 542-550.
DOI
ScienceOn
|
10 |
Larrabee A. Time-dependent changes in the size distribution of disteroylphos-phatidylcholine vesicles. Biochemistry. 1979. 18: 3321.
DOI
ScienceOn
|
11 |
Lee CM, Lee HC, Lee KY. O-palmitoylcurdlan sulfate (OPCurS)- coated liposomes for oral drug delivery. J Biosci Bioeng. 2005. 100: 255-259.
DOI
ScienceOn
|
12 |
Moreia JN, Almeida LM, Geraldes CF, Costa ML. Evaluation of in vitro stability of large unilamellar liposomes coated with a modified polysaccharide (O-palmitoylpullulan). J Mater Sci:Mater Med. 1996. 7: 301-303.
DOI
ScienceOn
|
13 |
Manconi M, Mura S, Manca ML, Fadda AM, Dolz M, Hernandez MJ, Casanovas A, Díez-Sales O. Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization. Int J Pharm. 2010. 392: 92-100.
DOI
|
14 |
Minato S, Iwanaga K, Kakemi M, Yamashita S, Oku N. Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: effect of lipid dose on systemic and mucosal immunity. J Control Release. 2003. 89: 189-197.
DOI
ScienceOn
|
15 |
Miyazaki Y, Ogihara K, Yakou S, Nagai T, Takayama K. In vitro and vivo evaluation of mucoadhesive microspheres consisting of dextran derivatives and cellulose acetate butyrate. Int J Pharm. 2003. 258: 21-29.
DOI
|
16 |
Parmentier J, Becker MM, Heintz U, Fricker G. Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids. Int J Pharm. 2011. 405: 210 -217.
DOI
|
17 |
Porta R, Mariniello L, Di Pierro P, Sorrentino A, Giosafatto CV. Transglutaminase crosslinked pectin- and chitosan-based edible films: a review. Crit Rev Food Sci Nutr. 2011. 51: 223 -238.
DOI
ScienceOn
|
18 |
Barea MJ, Jenkins MJ, Gaber MH, Bridson RH. Evaluation of liposomes coated with a pH responsive polymer. Int J Pharm. 2010. 402: 89-94.
DOI
|
19 |
Cao J, Sun J, Wang X, Li X, Deng Y. N-trimethyl chitosan-coated multivesicular liposomes for oxymatrine oral delivery. Drug Dev Ind Pharm. 2009. 35: 1339-1347.
DOI
ScienceOn
|
20 |
Childers NK, Denys FR, McGee NF, Michalek SM. Ultrastructural study of liposome uptake by M cell of rat Peyer's patch: an oral vaccine system for delivery of purified antigen. Reg Immunol. 1990. 3: 289-296.
|
21 |
Demarger-Andre S, Domard A. Chitosan behaviours in a dispersion of undecylenic acid. Carbohyd Polym. 1993. 22: 117-126.
DOI
ScienceOn
|
22 |
Dodane V, Khan MA, Merwin JR. Effect of chitosan on epithelial permeability and structure. Int J Pharm. 1999. 182: 21-32.
DOI
ScienceOn
|
23 |
Gregoriadis G. Immunological adjuvants: a role for liposomes. Immunol Today 1990. 11: 89-96.
DOI
|
24 |
Guo J, Ping Q, Jiang G, Huang L, Tong Y. Chitosan-coated liposomes: characterization and interaction with leuprolide. Int J Pharm. 2003. 260: 167-173.
DOI
ScienceOn
|
25 |
Han M, Watarai S, Kobayashi K, Yasuda T. Application of liposomes for development of oral vaccines: Study of in vitro stability of liposomes and antibody response to antigen associated with liposomes after oral immunization. J Vet Med Sci. 1997. 59: 1109-1114.
DOI
ScienceOn
|
26 |
Henriksen I, Vågen SR, Snade SA, Smistad G, Karlsen J. Interaction between liposomes and chitosan II: effect of selected parameters on aggregation and leakage. Int J Pharm. 1997. 146: 193-204.
DOI
ScienceOn
|
27 |
He P, Davis SS, Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm. 1998. 166: 75-88.
DOI
ScienceOn
|
28 |
He S, Zhu J, Xie F. Preparation and characterization of tramadol PEG-coated multivesicular liposomes for sustained release. Pharmazie. 2010. 65: 467-470.
|
29 |
Illum L, Jabbal-Gill I, Hinchcliffe M, Fisher AN, Davis SS. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev. 2001. 51: 81-96.
DOI
|
30 |
Kokkona M, Kallinteri P, Fatiuros D, Antimisiaris SG. Stability of SUV liposomes in the presence of cholate salts and pancreatic lipase: effect of lipid composition. Eur J Pharm Sci. 2000. 9: 245-252.
DOI
ScienceOn
|